Patents by Inventor David Kinniburgh Lang

David Kinniburgh Lang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLUID CONTROL IN MICROFLUIDIC DEVICES
    Publication number: 20230144460
    Abstract: A diagnostic system for determining the presence of a target in a sample liquid that includes a diagnostic reader and a microfluidic strip having a microfluidic channel network therein. An actuator within the reader modifies the pressure of a gas in gaseous communication with a liquid-gas interface of a sample liquid within the microfluidic channel network to move and/or mix the sample liquid. The pressure modifications may be continuous and/or oscillatory.
    Type: Application
    Filed: July 8, 2022
    Publication date: May 11, 2023
    Inventors: Aman Murtaza Khan, Badr Aman Khan, Brian McGuigan, David William Taylor, David Kinniburgh Lang, John Iain William Deane, Lois Bello Fernandez De Sanmamed, Michael Flett, Phill Lowe, Steven Alexander Keatch, Usman Ali Khan, Dave Scott, Thomas J. Quinlan, Nigel Malcolm Lindner, Marcus Twomey, Graeme John McInnes
  • METHODS AND COMPOSITIONS FOR MONITORING HEART FAILURE
    Publication number: 20170140122
    Abstract: The present invention provides methods and compositions for monitoring of subjects suffering from, or being evaluated for, heart failure. A filtered Natriuretic peptide time-series, alone or in combination with other clinical indicia such as weight gain, can be used to estimate a patient's hazard (risk of decompensation). The cumulative integral of Natriuretic peptide concentration can be used to estimate cumulative hazard (risk times exposure) over longer periods of exposure, e.g., 14 day periods, or 30 day periods.
    Type: Application
    Filed: June 3, 2016
    Publication date: May 18, 2017
    Inventors: Kenneth Kupfer, Richard C. Sangeorge, Jerome Mcaleer, Kevin Keegen, David Kinniburgh Lang
  • METHODS AND COMPOSITIONS FOR MONITORING HEART FAILURE
    Publication number: 20150169840
    Abstract: The present invention provides methods and compositions for monitoring of subjects suffering from, or being evaluated for, heart failure. A filtered Natriuretic peptide time-series, alone or in combination with other clinical indicia such as weight gain, can be used to estimate a patient's hazard (risk of decompensation). The cumulative integral of Natriuretic peptide concentration can be used to estimate cumulative hazard (risk times exposure) over longer periods of exposure, e.g., 14 day periods, or 30 day periods.
    Type: Application
    Filed: August 3, 2012
    Publication date: June 18, 2015
    Applicant: Alere San Diego, Inc.
    Inventors: Kenneth Kupfer, Richard C. Sangeorge, Jerome Mcaleer, Kevin Keegen, David Kinniburgh Lang
  • Assay device and method
    Publication number: 20090130771
    Abstract: An assay device includes a first reagent including a magnetic particle and a second reagent including detectable component. The first and second reagent can each independently bind to an analyte in a sample. Applying a magnetic field can selectively concentrate the detectable component in a detection zone, where a detectable change ca be measured and related to the amount of analyte in the sample.
    Type: Application
    Filed: July 19, 2006
    Publication date: May 21, 2009
    Applicant: Inverness Medical Switzerland GMBH
    Inventors: Oliver William Hardwicke Davies, David Kinniburgh Lang, John William Dilleen, Phillip Lowe, Steven Howell, Christopher John Slevin
  • Test strip
    Patent number: D621059
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: August 3, 2010
    Assignee: Alere Switzerland GmbH
    Inventors: Claus Marquordt, David William Taylor, Colin Hanna, David Kinniburgh Lang, Brian McGuigan, Colin Boyd, Jonathan Chua Cheng Lam, Allen Lai Siew Kong, Chun Keat Ooi